drug
omidubicel
Phase 3updated 6mo agoby Gamida Cell Ltd
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying omidubicel
- phase3Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
- phase3Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies
- —Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients
News(2)
- Karyopharm files for bankruptcy, looks to merger with Ayrmid for life raftDebtor-in-process financing up to $55 million could keep the lights on at Karyopharm Therapeutics for its multiple myeloma and myelofibrosis programs as the biotech waits to see if its union with A…biospace · 15d ago
- Karyopharm files Chapter 11, lines up Ayrmid as lead bidder in planned mergerIn an answer to Karyopharm's cash crisis, Irish biotech Ayrmid has agreed to make the first bid on the struggling biopharma's assets in a court supervised auction, teeing up a potential hematology…fiercebiotech · 15d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that